The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Helius Medical Technologies announced its subsidiary NeuroHabilitation executed an extension to its research and development agreement with the US Army Medical Research and Materiel Command through 2018.
Tetra Bio-Pharma incorporated Dr. Louis-Philippe de Lorimier into their clinical advisory board for the veterinary market.
GT Biopharma announced it made the payment for the license of PainBrake, a non-opioid medication from Accu-Break Pharmaceuticals, which the company plans to develop.
By Jocelyn Aspa
Glance Technologies (CSE:GET.CN) has announced that its partially-owned subsidiary, Cannapay Financial, has entered into an agreement to acquire the rights to a package of holistic Ayurveda formulas intended to treat a number of ailments.
As quoted in the press release:
Cannapay has agreed to purchase all of the intellectual property pertaining to
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Thanks to their second quarter financial reports these medical device companies are experiencing growth in their stocks.
Medovex announced it obtained approval from the Australian Therapeutic Goods Administration for their DenerveX System.
By Shelly Kumar
Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces it proudly exhibited at the US Autism & Asperger Association (USAAA) (http://usautism.org/conferences/schedule.html) conference this past weekend in Portland, Oregon and sponsored Dr. Ronald Aung-Din to educate
Medovex provided a 30-day post procedure update on one of the first cases using its DenerveX System.
By Jocelyn Aspa
The Investing News Network recently had the opportunity to speak with Nick Dinsmoor, vice president, strategic marketing, of VirtualArmour about the company’s new managed service contracts and the cybersecurity industry as a whole.